z-logo
open-access-imgOpen Access
Efficacy of Nonpharmacological Treatments on Comorbid Internalizing Symptoms of Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
Author(s) -
López-Pinar Carlos,
Martínez-Sanchís Sonia,
Carbonell-Vayá Enrique,
Sánchez-Meca Julio,
Fenollar-Cortés Javier
Publication year - 2020
Publication title -
journal of attention disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 72
eISSN - 1557-1246
pISSN - 1087-0547
DOI - 10.1177/1087054719855685
Subject(s) - psychology , neurofeedback , clinical psychology , mindfulness , attention deficit hyperactivity disorder , meta analysis , randomized controlled trial , depression (economics) , anxiety , moderation , quality of life (healthcare) , comorbidity , cognitive behavioral therapy , psychiatry , medicine , psychotherapist , macroeconomics , electroencephalography , economics , social psychology
Background: Attention-deficit/hyperactivity disorder (ADHD) is highly comorbid in adulthood. This meta-analysis was aimed at ascertaining the efficacy of different psychotherapies in improving comorbid internalizing symptoms in adults with ADHD. Method: Twenty randomized controlled trials and 12 uncontrolled pretest–posttest studies were included and combined using the inverse variance method. Risk of bias and heterogeneity assessment and moderator analyses were performed. Results: Cognitive-behavioral therapy (CBT) improved quality of life (QoL), emotional dysregulation (ED), depression, and anxiety symptoms, particularly at follow-up, which was predicted by core symptoms reduction. A significant between-group effect was obtained only on QoL, ED, and self-esteem for dialectical behavior therapy (DBT), mindfulness-based therapies (MBTs), and neurofeedback, respectively. Conclusion: Results support CBT efficacy for treating comorbid internalizing symptoms. More research is needed to determine the effectiveness of DBT, MBT, and neurofeedback. The small number of studies evaluating some therapies and the high risk of bias observed might limit these results.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom